Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015441
Filing Date
2025-06-03
Accepted
2025-06-03 17:37:07
Documents
1
Period of Report
2025-05-30

Document Format Files

Seq Description Document Type Size
1 form4-06032025_090659.html 4  
1 form4-06032025_090659.xml 4 4168
  Complete submission text file 0001415889-25-015441.txt   5549
Mailing Address
Business Address
FLUKE JOHN M JR (Reporting) CIK: 0001191906 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 251021137

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)